tradingkey.logo

TruBridge Inc

TBRG
19.420USD
+0.180+0.94%
Close 11/07, 16:00ETQuotes delayed by 15 min
291.59MMarket Cap
LossP/E TTM

TruBridge Inc

19.420
+0.180+0.94%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of TruBridge Inc

Currency: USD Updated: 2025-11-07

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

TruBridge Inc's Score

Industry at a Glance

Industry Ranking
81 / 209
Overall Ranking
176 / 4614
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 4 analysts
Buy
Current Rating
24.750
Target Price
+28.64%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

TruBridge Inc Highlights

StrengthsRisks
TruBridge, Inc. is a provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. The Company operates through three segments: RCM, HER and Patient Engagement. The RCM segment focuses on providing a complete revenue cycle management (RCM) solution for all care settings, regardless of their primary healthcare information solutions provider, along with business management, consulting, managed IT services, analytics and business intelligence. The EHR segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. The Patient Engagement segment offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. Its wholly owned subsidiaries include Viewgol, LLC, iNetXperts, Corp. doing business as Get Real Health, Healthcare Resource Group, Inc. and Healthland Holding Inc.
Undervalued
The company’s latest PE is -25.87, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 10.38M shares, decreasing 24.95% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 755.37K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.29.

Financial Health

Currency: USD Updated: 2025-11-07

The company's current financial score is 7.95, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 85.73M, representing a year-over-year increase of 1.18%, while its net profit experienced a year-over-year increase of 151.62%.

Score

Industry at a Glance

Previous score
7.95
Change
0

Financials

4.51

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

10.00

Operational Efficiency

10.00

Growth Potential

7.90

Shareholder Returns

7.33

TruBridge Inc's Company Valuation

Currency: USD Updated: 2025-11-07

The company’s current valuation score is 8.29, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -25.87, which is -402.90% below the recent high of 78.37 and -1136.46% above the recent low of -319.92.

Score

Industry at a Glance

Previous score
8.29
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 81/209
No Data

Earnings Forecast

Currency: USD Updated: 2025-11-07

The company’s current earnings forecast score is 7.00, which is lower than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for TruBridge Inc is 25.50, with a high of 28.00 and a low of 20.00.

Score

Industry at a Glance

Previous score
7.00
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 4 analysts
Buy
Current Rating
24.750
Target Price
+28.64%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

89
Total
4
Median
7
Average
Company name
Ratings
Analysts
TruBridge Inc
TBRG
4
Boston Scientific Corp
BSX
37
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
35
Veeva Systems Inc
VEEV
34
Thermo Fisher Scientific Inc
TMO
28
1
2
3
...
18

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-07

The company’s current price momentum score is 6.72, which is lower than the Healthcare Equipment & Supplies industry's average of 6.88. Sideways: Currently, the stock price is trading between the resistance level at 20.78 and the support level at 18.26, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.59
Change
0.13

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(4)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
0.018
Neutral
RSI(14)
43.964
Neutral
STOCH(KDJ)(9,3,3)
43.785
Neutral
ATR(14)
0.659
High Vlolatility
CCI(14)
51.625
Neutral
Williams %R
61.829
Sell
TRIX(12,20)
-0.218
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
19.272
Buy
MA10
19.338
Buy
MA20
19.559
Sell
MA50
20.107
Sell
MA100
20.822
Sell
MA200
23.386
Sell

Institutional Confidence

Currency: USD Updated: 2025-11-07

The company’s current institutional recognition score is 5.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.42. The latest institutional shareholding proportion is 69.15%, representing a quarter-over-quarter decrease of 20.53%. The largest institutional shareholder is The Vanguard, holding a total of 755.37K shares, representing 5.03% of shares outstanding, with 15.88% increase in holdings.

Score

Industry at a Glance

Previous score
5.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Pinetree Capital Ltd.
2.67M
+2.70%
Ocho Investments, L.L.C.
1.11M
--
Rorema Beheer B.V.
950.16K
+24.95%
Nellore Capital Management LLC
683.92K
+215.31%
The Vanguard Group, Inc.
Star Investors
750.49K
+13.05%
BlackRock Institutional Trust Company, N.A.
674.04K
+166.22%
Martin & Company Investment Counsel
370.61K
-3.66%
Dimensional Fund Advisors, L.P.
407.48K
+17.94%
Columbia Threadneedle Investments (US)
291.13K
-35.15%
Federated MDTA LLC
292.06K
-36.05%
1
2

Risk Assessment

Currency: USD Updated: 2025-11-07

The company’s current risk assessment score is 5.80, which is higher than the Healthcare Equipment & Supplies industry's average of 4.58. The company's beta value is 0.61. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
5.80
Change
0
Beta vs S&P 500 index
0.61
VaR
+3.75%
240-Day Maximum Drawdown
+37.16%
240-Day Volatility
+50.83%

Return

Best Daily Return
60 days
+3.91%
120 days
+3.91%
5 years
+24.46%
Worst Daily Return
60 days
-4.30%
120 days
-10.76%
5 years
-19.66%
Sharpe Ratio
60 days
-0.35
120 days
-1.47
5 years
-0.01

Risk Assessment

Maximum Drawdown
240 days
+37.16%
3 years
+75.54%
5 years
+79.46%
Return-to-Drawdown Ratio
240 days
+0.57
3 years
-0.13
5 years
-0.09
Skewness
240 days
-0.16
3 years
+0.01
5 years
-0.43

Volatility

Realised Volatility
240 days
+50.83%
5 years
+45.34%
Standardised True Range
240 days
+5.06%
5 years
+4.29%
Downside Risk-Adjusted Return
120 days
-165.30%
240 days
-165.30%
Maximum Daily Upside Volatility
60 days
+25.09%
Maximum Daily Downside Volatility
60 days
+20.47%

Liquidity

Average Turnover Rate
60 days
+1.07%
120 days
+1.10%
5 years
--
Turnover Deviation
20 days
-28.62%
60 days
+3.09%
120 days
+5.69%

Peer Comparison

Healthcare Equipment & Supplies
TruBridge Inc
TruBridge Inc
TBRG
7.06 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Castle Biosciences Inc
Castle Biosciences Inc
CSTL
8.63 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
Cencora Inc
COR
8.62 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
TCMD
8.60 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
STERIS plc
STERIS plc
STE
8.54 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.53 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI